Tvardi Therapeutics (TVRD) Enterprise Value (2014 - 2026)
Tvardi Therapeutics' Enterprise Value came in at $2.02 million for Q2 2026, down 98.9% from $177.69 million a year earlier and down 57.8% from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Enterprise Value (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Tvardi Therapeutics reported Enterprise Value of -$90.28 million; for FY2025, it was $1.09 million.
- Enterprise Value carries a five-year compound annual growth rate of -71.4% (FY2020 to FY2025).
- Going back by year, Enterprise Value was -$3.64 million in FY2024, -$60.28 million in FY2023, $432.36 million in FY2022 (-10.7%) and $484.33 million in FY2021 (-15.6%).
- The five-year range for quarterly Enterprise Value is -$60.28 million (Q4 2023) to $630.99 million (Q3 2021).
- The fastest year-over-year change in Enterprise Value over five years came in Q3 2021 (growth of 32.6%), and the weakest in Q2 2026 (a decline of 98.9%).
- Business Quant data shows TVRD's Enterprise Value at $4.8 million (Q1 2026), $1.09 million (Q4 2025) and $329.05 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.02 Bn | 1,101.60 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn |
| 4 | Merck | 366.78 Bn | 321.16 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.96 Bn | 261.95 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.44 Bn | 190.84 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.69 Bn | 164.89 Bn | 6.22 Bn |
| 9 | Pfizer | 169.52 Bn | 116.16 Bn | 10.94 Bn |
| 10 | Tvardi Therapeutics | 9.85 Mn | -98.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.02 Mn |
| Mar 31, 2026 | 4.80 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 329.05 Mn |
| Jun 30, 2025 | 177.69 Mn |
| Mar 31, 2025 | -11.04 Mn |
| Dec 31, 2024 | -3.64 Mn |
| Sep 30, 2024 | -25.14 Mn |
| Jun 30, 2024 | -42.47 Mn |
| Mar 31, 2024 | -20.03 Mn |
| Dec 31, 2023 | -60.28 Mn |
| Sep 30, 2023 | 12.97 Mn |
| Jun 30, 2023 | 58.32 Mn |
| Mar 31, 2023 | 150.72 Mn |
| Dec 31, 2022 | 432.36 Mn |
| Sep 30, 2022 | 347.31 Mn |
| Jun 30, 2022 | 332.84 Mn |
| Mar 31, 2022 | 509.99 Mn |
| Dec 31, 2021 | 484.33 Mn |
| Sep 30, 2021 | 630.99 Mn |
API Access
Tvardi Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();